Human cells can ’silence’ HIV genes

For the first time, scientists have shown that humans use an immune defense process common in plants and invertebrates to battle a virus. The new finding that human cells can silence an essential part of HIV’s genetic make-up could have important implications for the treatment of people infected with the virus. Led by Kuan-Teh Jeang, M.D, Ph.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part the National Institutes of Health, the researchers published their findings in this week’s issue of the journal Immunity.


“This research suggests that a novel approach to HIV therapy targeting a stable component of HIV might be feasible,” says NIAID Director Anthony S. Fauci, M.D.

The phenomenon, called RNA silencing, was detected first in plants and later in insects. Although plants and insects lack the sophisticated immune defenses of higher organisms, they nevertheless successfully battle viruses by detecting, and then silencing, viral genetic material. Silencing leads to the destruction of viral RNA. Viruses, however, are not permanently defeated because they have evolved ways to suppress the silencing action.

Until now, scientists have not had clear evidence that RNA silencing plays a role in the defensive repertoire of mammals and other vertebrates. Dr. Jeang and his colleagues set out to determine if RNA silencing (also called RNA interference or RNAi) contributes to human cells’ defense against HIV.

They asked three questions. First, does HIV have genetic sequences that an HIV-infected cell can detect and transform into the necessary precursors of RNAi, called short interfering RNA (siRNA)? Second, do human cells use siRNAs to disable HIV? Third, if human cells try to battle HIV using RNAi, does HIV have a way to evade the defensive maneuver? The answer to all three questions, the scientists determined, is yes.

The most unexpected finding, according to Dr. Jeang, was the way HIV uses one of its proteins, called Tat, to suppress the silencing efforts of the cell. HIV is well known for evading drugs by quickly mutating its genes. However, the virus could not evade the newly discovered sequence-specific siRNA attack by mutation. Instead, HIV required a virally encoded protein to blunt the assault. Dr. Jeang believes that Tat may be shielding a rare HIV Achilles’ heel, a genetic sequence that, for functional reasons, the virus cannot change in order to escape siRNA attack. This novel siRNA sequence discovered by the team may lead to the development of new RNAi-based drugs to which HIV would not be able to develop resistance by simple mutation.

Media Contact

Anne A. Oplinger EurekAlert!

More Information:

http://www.niaid.nih.gov

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors